GLP-1 Agonists

Clinical Update

Medication Management of Antipsychotic-Induced Weight Gain in Children and Teens

Topics: body mass index BMI | GLP-1 Agonists | Metformin | Second Generation Antipsychotics (SGAs) | Topiramate | Weight gain

Of approximately one million US children and adolescents, roughly 1% are prescribed second-generation antipsychotics (SGAs). These medications routinely breach the FDA’s level of concern of >7% body weight gain. The worst offenders are olanzapine, quetiapine, and risperidone; lurasidone and ziprasidone are of less concern (Maayan L and Correll CU,

Read More